OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 24 citing articles:

Facile electrochemical determination of sertraline at nanomolar concentration using bimetallic MXene NbTiCTx and MWCNTs hybridized electrodes as sensing platform
Nana Tang, Yanping Wei, Quanguo He, et al.
Materials Today Chemistry (2024) Vol. 36, pp. 101901-101901
Closed Access | Times Cited: 14

Psychopharmacology in children and adolescents: unmet needs and opportunities
Samuele Cortese, Diane Purper‐Ouakil, Alan Apter, et al.
The Lancet Psychiatry (2023) Vol. 11, Iss. 2, pp. 143-154
Open Access | Times Cited: 14

Safety Outcomes from a Long-Term, Prospective Study of Sertraline Use in Children and Adolescents: The Sertraline Pediatric Registry for the Evaluation of Safety
Sara Ramaker, Francesca Kolitsopoulos, Lisa Ludwig, et al.
Journal of Child and Adolescent Psychopharmacology (2025)
Closed Access

Submicron spherical carbon modified boron-doped diamond for sensitive detection of sertraline hydrochloride
Siyu Xu, Xiaoyu Li, Yueling Zhang, et al.
Diamond and Related Materials (2025), pp. 112298-112298
Closed Access

Current Status of Therapeutic Drug Monitoring in Mental Health Treatment: A Review
Filippo Pennazio, Claudio Brasso, Vincenzo Villari, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2674-2674
Open Access | Times Cited: 19

Machine Learning‐Based Prediction of Escitalopram and Sertraline Side Effects With Pharmacokinetic Data in Children and Adolescents
Ethan A. Poweleit, Samuel Vaughn, Zeruesenay Desta, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 4, pp. 860-870
Open Access | Times Cited: 3

Population pharmacokinetic modeling study and discovery of covariates for the antidepressant sertraline, a serotonin selective reuptake inhibitor
Ji-Hun Jang, Seung‐Hyun Jeong
Computers in Biology and Medicine (2024) Vol. 183, pp. 109319-109319
Closed Access | Times Cited: 2

Artificial intelligence-based model for dose prediction of sertraline in adolescents: a real-world study
Ran Fu, Ze Yu, Chunhua Zhou, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 177-187
Closed Access | Times Cited: 1

Pharmacogenomic and pharmacometabolomic biomarkers of the efficacy and safety of antidepressants: focus on selective serotonin reuptake inhibitors
А. Э. Гареева, Liliya Borodina, S A Pozdnyakov, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 6, pp. 26-26
Closed Access | Times Cited: 1

TRATAMIENTO DE LA ANSIEDAD Y DEPRESIÓN EN PEDIATRÍA: REVISIÓN DE AVANCES RECIENTES.
Zully Stefania Cedeño Roballino, Miguel Anderson Tayupanta Alban, Jazmín Natalie Gallegos Polo, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 3, pp. 2944-2955
Open Access

Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine
Regina Taurines, Gesa Kunkel, Stefanie Fekete, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 772-772
Open Access

Pharmacogenomic and Pharmacometabolomic Biomarkers of the Efficacy and Safety of Antidepressants: Focus on Selective Serotonin Reuptake Inhibitors
А. Э. Гареева, Liliya Borodina, S A Pozdnyakov, et al.
Neuroscience and Behavioral Physiology (2024)
Closed Access

Dosing of antidepressants in relation to body weight in children and adolescents with overweight
Júlia Izsák, Elin Kimland, Jari Martikainen, et al.
International Journal of Obesity (2024)
Open Access

Toward therapeutic drug monitoring of citalopram in depression? Insights from a systematic review
Na Xu, Zaiwei Song, Dan Jiang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1

Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
Michael Frey, Lukasz Smigielski, E. Tini, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2202-2202
Open Access | Times Cited: 1

An overview of the pharmacological options for pediatric obsessive-compulsive disorder
Donatella Marazziti, Andrea Pozza
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 16, pp. 1793-1800
Closed Access | Times Cited: 1

Etiology and Treatment of Anxiety
Suo Qin
BIO Web of Conferences (2023) Vol. 59, pp. 02006-02006
Open Access

Treatment in Children and Adolescents With Obsessive-Compulsive Disorder: Review for Practitioners
Fatima Ramos-Marcuse, Karan Kverno
Journal of Psychosocial Nursing and Mental Health Services (2023) Vol. 61, Iss. 8, pp. 11-15
Closed Access

Zwangsstörungen im Kindes- und Jugendalter
Susanne Walitza, Christoph Wewetzer
Springer eBooks (2023), pp. 777-788
Closed Access

Entwicklungspsychopharmakologie
Manfred Gerlach, Karin Egberts, Regina Taurines, et al.
Springer eBooks (2023), pp. 87-99
Closed Access

A EFICÁCIA E A SEGURANÇA DOS ANTIDEPRESSIVOS EM CRIANÇAS E ADOLESCENTES NA PRÁTICA CLÍNICA: UMA REVISÃO DE LITERATURA
GABRIEL NUNES MARTINS, HENRIQUE SILVA FERREIRA, PAULO VINÍCIUS COSTA MORESI, et al.
Editora Pasteur eBooks (2022), pp. 35-41
Open Access

Page 1

Scroll to top